中文
Home
About Sungen
Company Profile
News
Nattokinase
EsseZyme™
Health Effect
Vitamin K2(MK-7)
ESSEK2
®
Health Effect
Other Ingredients
r-Hirudin™
γ-PGA
ExtraBroth™
Research
Clinical Research Project
Thesis
Contact
Company Profile
News
News
Home
>
About Sungen
>
News
SungenBio was selected as the top ten pos...
Date: 2020-02-28
2017 China Pharmaceutical Quality Annual Meeting: SungenBio"Natto Physioactive Sub...
SungenBio:Nattokinase was Awarded the Substantive Equivalence Opinion of the EU Novel F...
New Discovery • Make Life More Wonderful - Opening Ceremony of Vitamin K2 Research Cen...
SungenBio Become China's Only "Natto Physiological Active Substances Producti...
The NHFPC Has Approved Vitamin K2 as Nutrition Supplements
Sungenbio Attended The 16th CPHI China for Promoting FU as a Standard Activity Unit of ...
The quality mobilization meeting“Quality, my responsibility” was held
The purification technology of Vitamin K2 obtained national invention patent
NattoK2™ obtained EU novel food substantial equivalence issued by FSAI
Innovation-driven leading industry—2016 new trends in Sungen
SungenBio announced nattokinase activity detection standard in CPHI China
Vitamin K2 for export declaration by SungenBio
<<
<
1
2
3
4
>
>>
Nattokinase
EsseZyme™
Health Effect
Vitamin K2(MK-7)
ESSEK2
®
Health Effect
Other Ingredients
r-Hirudin™
γ-PGA
ExtraBroth™
Contact
Tel:+86-754-88819999
Fax:+86-754-83595599
Email:
sungenbio@163.com
COPYRIGHT © 2019 Sungen Bioscience Co.,Ltd
Technical support:
Lanhai Net